Glenmark Pharmaceuticals U.S. > News

News

Press Releases

Get access to Glenmark information and resources for stories in development.
Find recent and archived press releases.

Glenmark unveils its Strategic Blueprint for Transition into an Innovation-Led Global Pharmaceutical Organization in the Next Decade

December 20, 2016

Glenmark unveils its Strategic Blueprint for Transition into an Innovation-Led Global Pharmaceutical Organization in the Next Decade

December 19, 2016

Glenmark launches first and only generic version of Zetia® in the United States

December 12, 2016

Glenmark Announces Pre-Clinical Data Results for Experimental GBR 1302-BEAT Technology

November 4, 2016

Glenmark Pharmaceuticals Announces Pre-Clinical Data Results for Experimental GBR 1302-BEAT Technology

November 4, 2016

News

Search Result :-

Is an investigational new drug that has not been approved for commercial distribution in the United States.

December 20, 2016
Glenmark unveils its Strategic Blueprint for Transition into an Innovation-Led Global Pharmaceutical Organization in the Next Decade

December 19, 2016
Glenmark unveils its Strategic Blueprint for Transition into an Innovation-Led Global Pharmaceutical Organization in the Next Decade

December 12, 2016
Glenmark launches first and only generic version of Zetia® in the United States

November 4, 2016
Glenmark Announces Pre-Clinical Data Results for Experimental GBR 1302-BEAT Technology

November 4, 2016
Glenmark Pharmaceuticals Announces Pre-Clinical Data Results for Experimental GBR 1302-BEAT Technology

US Media Contact

For media inquiries only, please contact Corporate Communications.
uscomms@glenmarkpharma.com

Investor Relations

For more information on Glenmark Pharmaceuticals Ltd., including Annual Reports, Analyst Presentations and Financial Results, please visit our Investor Relations.

POTASSIUM CHLORIDE EXTENDED RELEASE CAPSULES 750mg RECALL REIMBURSEMENT POLICY

Over-the-counter (OTC)

ACCESSIBLE PRODUCTS

Who We Are

Injectables

OUR GROWING LINE